UCB

CIMZIA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / CIMZIA – J0717

Manufacturer:

UCB

Name:

CIMZIA

HCPCS Code Descriptor:

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Category:

J Code

HCPCS:

J0717

NDC(s):

50474-0710-81, 50474-0710-79, 50474-0700-62

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

CIMZIA is an Immunology:Anti-TNF drug manufactured by UCB and administered via the Subcutaneous route of administration. The J Code: J0717 is aligned to the drug CIMZIA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/14

HCPCS Effective Date:

1/1/14

HCPCS Short Description:

Certolizumab pegol inj 1mg

Billing and Coding Guide:

https://www.cimziainoffice.com/sites/default/files/2023-01/US-P-CZ-AS-2200281_FRE_CZP_Process_Guide_Digital_121222.pdf

Patient Assistance:

https://www.ucb-usa.com/Patients/Patients

CIMZIA - J0717